New Key Statistics Module, Z-Score and F-Score
OTCPK:RGTLF Key Ratios
Market Cap $ M | 9.05 |
Enterprise Value $ M | 5.04 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 8.11 |
Price/Sales | 1.15 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -2.15 |
Beneish M-Score | -6.17 |
10-y EBITDA Growth Rate % | 9.90 |
5-y EBITDA Growth Rate % | -13.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.46 |
EV-to-EBITDA | -0.49 |
PEG | -- |
Shares Outstanding M | 45.28 |
Net Margin (%) | -1,020.20 |
Operating Margin % | -944.42 |
Pre-tax Margin (%) | -1,028.42 |
Quick Ratio | 0.66 |
Current Ratio | 0.76 |
ROA % (ttm) | -119.95 |
ROE % (ttm) | -- |
ROIC % (ttm) | -86.32 |
Dividend Yield % | -- |
Altman Z-Score | -24.12 |
RGTLF Number of Guru Trades
RGTLF Volume of Guru Trades
Gurus Latest Trades with OTCPK:RGTLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:RGTLF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Argent Biopharma Ltd Insider Transactions
No Available Data
News about OTCPK:RGTLF
Total 0- 1